会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Membranes having improved performance
    • 具有改进性能的膜
    • US08827087B2
    • 2014-09-09
    • US13320679
    • 2010-05-19
    • Bernd KrauseCarina Zweigart
    • Bernd KrauseCarina Zweigart
    • B01D71/68B01D69/08B01D71/76B29C47/12B01D71/40B01D67/00
    • B01D69/08B01D67/0088B01D67/0093B01D71/40B01D71/68B01D71/76
    • Permselective asymmetric membranes suitable e.g. for hemodialysis, hemodiafiltration and hemofiltration of blood, and having improved sieving characteristics providing enhanced removal of middle molecular weight substances, e.g. inflammatory mediators having a molecular weight between 20 and 40 kDa. The membranes comprise polyethersulfone and polyvinylpyrrolidone and are coated with hyaluronic acid or copolymers of 2-methacryloyloxyethyl phosphoryl choline and other vinyl polymerizable monomers. Processes for the preparation of these membranes, devices comprising these membranes, and the use of these membranes in hemodialysis, hemodiafiltration and hemofiltration of blood, as well as in bioprocessing, plasma fractionation and the preparation of protein solutions.
    • 选择性不对称膜适合于例如 用于血液透析,血液透析过滤和血液的血液滤过,并且具有改善的筛分特性,提供中等分子量物质的增强除去。 具有20至40kDa分子量的炎性介质。 膜包含聚醚砜和聚乙烯吡咯烷酮,并用透明质酸或2-甲基丙烯酰氧基乙基磷酰胆碱和其它乙烯基可聚合单体的共聚物涂覆。 用于制备这些膜的方法,包括这些膜的装置以及这些膜在血液透析,血液透析滤过和血液血液滤过以及生物处理,血浆分离和蛋白质溶液的制备中的用途。
    • 7. 发明申请
    • MEMBRANES HAVING IMPROVED PERFORMANCE
    • 具有改进性能的膜
    • US20120074063A1
    • 2012-03-29
    • US13320679
    • 2010-05-19
    • Bernd KrauseCarina Zweigart
    • Bernd KrauseCarina Zweigart
    • B01D71/68B29C47/12B01D67/00B01D61/24B01D69/08
    • B01D69/08B01D67/0088B01D67/0093B01D71/40B01D71/68B01D71/76
    • Permselective asymmetric membranes suitable e.g. for hemodialysis, hemodiafiltration and hemofiltration of blood, and having improved sieving characteristics providing enhanced removal of middle molecular weight substances, e.g. inflammatory mediators having a molecular weight between 20 and 40 kDa. The membranes comprise polyethersulfone and polyvinylpyrrolidone and are coated with hyaluronic acid or copolymers of 2-methacryloyloxyethyl phosphoryl choline and other vinyl polymerizable monomers. Processes for the preparation of these membranes, devices comprising these membranes, and the use of these membranes in hemodialysis, hemodiafiltration and hemofiltration of blood, as well as in bioprocessing, plasma fractionation and the preparation of protein solutions.
    • 选择性不对称膜适合于例如 用于血液透析,血液透析过滤和血液的血液滤过,并且具有改善的筛分特性,提供中等分子量物质的增强除去。 具有20至40kDa分子量的炎性介质。 膜包含聚醚砜和聚乙烯吡咯烷酮,并用透明质酸或2-甲基丙烯酰氧基乙基磷酰胆碱和其它乙烯基可聚合单体的共聚物涂覆。 用于制备这些膜的方法,包括这些膜的装置以及这些膜在血液透析,血液透析滤过和血液血液滤过以及生物处理,血浆分离和蛋白质溶液的制备中的用途。